Bladder Cancer Clinical Trial

Urine Proteome of Surgical Patients and Healthy Volunteers

Summary

The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years and older
Planned procedure with presumptive diagnosis of RCC, bladder or prostate cancer OR control patient undergoing non-urological surgery OR normal healthy volunteer OR post surgical patient with a diagnosis of RCC and under surveillance for reoccurrence of RCC or treatment of metastatic RCC
Signed, informed consent

Exclusion Criteria:

Patients on dialysis

Study is for people with:

Bladder Cancer

Estimated Enrollment:

664

Study ID:

NCT01538823

Recruitment Status:

Completed

Sponsor:

Washington University School of Medicine

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Washington University School of Medicine
Saint Louis Missouri, 63110, United States

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

664

Study ID:

NCT01538823

Recruitment Status:

Completed

Sponsor:


Washington University School of Medicine

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider